Mark Rogers, MSc

Cofounder & CEO

15yrs+ in Emerging Biotech Business Development, Cell & Gene Therapy Research & Protein-Protein Interaction Screening. MSc in Molecular Biotechnology. Previously Associate Director- Emerging Biotech at Merck KGaA & Cofounder of Curogenix

Pavel Kartasevs, MEng

Cofounder & CTO

10yrs experience in High-Performance Computing, Machine Learning, NLP, Bioinformatics & Software Engineering. MEng in Computer Engineering, MSc in Bioinformatics. Previously Tech Lead at UK Tech Start-up & Tutor in Bioinformatics at Cranfield University.

Anna O'Leary, BA

Cofounder & COO

10yrs experience in Business Operations. BA in Business & Finance. Previously worked in management at Aramark, and in operations at RBS Global Banking & Markets (US) and at Aramark.

John Conway, MSc

Head of Machine Learning Research

20yrs in hands-on Data Analytics and Machine Learning research, and management of data science teams. MSc in Data Science. Previously, Director of Data Science at a FinTech startup.

David Kwon, MD, PhD, MBA

Advisor - Clinical Development & Digital Strategy

Currently, Executive Director of Clinical Development at Esperion. Previously, Global Medical Director at Novartis & Gilead.

Prof. Jody Haigh, PhD

Advisor - Oncology Pharmacology & Therapeutics

Professor of Pharmacology & Therapeutics, Haematological Oncology, CancerCare Manitoba. Previously worked at Monash University, Ghent University and the Research Institute of Molecular Pathology (IMP) in Vienna.

Bill Allison

Advisor - Business Strategy & Technology

Chief Technology Officer at UC Berkeley. Berkeley Skydeck Advisor.

Niranjan Tulpule, BEng

Advisor & Investor - Knowledge graphs and software development

Engineering Director at Google

Sam Mercer, BSc

Consultant - Strategy & Business Development

Consultant, and Board Chairperson Vancouver Island Life Sciences. Previously, worked in clinical trial outsourcing at Novartis and Roche, and business development at Eupraxia.

Partners